Hybrid revascularization effective for left main coronary blockages

Mar 15, 2010

The left main coronary artery provides most of the blood to the heart, and current guidelines call for patients with blockages in this artery to undergo bypass surgery.

Hybrid is a combination of coronary artery bypass surgery and percutaneous (PCI). Emory physicians have been performing these procedures “off-pump” in a minimally invasive fashion, without breaking open the chest. This technique is also known as “endo-ACAB” (endoscopic atraumatic ).

Syed Tanveer Rab, MD, assistant professor of medicine (cardiology), Emory University School of Medicine, will report on outcomes from 21 Emory patients with blockages in the left main coronary artery treated using hybrid revascularization.

The presentation takes place at the American College of Cardiology meeting in Atlanta on Monday, March 15.

Rab describes the Emory approach as a “best of both worlds strategy”: minimally invasive off-pump left internal mammary artery (LIMA) graft, plus a stent placed via ultrasound from the left main to the left circumflex artery.

For these patients, the average ICU stay was 1.1 +- 0.4 days. Fifteen patients had hybrid surgery and PCI in the same hospitalization and the rest had the two procedures a few days apart. All but one patient received a . Two had re-exploration with . No major adverse cardiac or cerebrovascular events were reported in the hospital or after 30 days.

The authors conclude:
“Hybrid revascularization for left main coronary artery stenosis appears to be a safe and feasible procedure in selected patients and may preserve the survival advantage imparted by the left internal mammary artery graft to the left anterior descending artery. A multicenter trial to assess intermediate and long term outcomes of this form of hybrid revascularization is warranted.”

Emory, Columbia University and Albert Einstein College of Medicine recently received a $1 million “Challenge” grant from the National Heart, Lung and Blood Institute to plan a large-scale clinical trial of hybrid revascularization.

Emory’s investigator on this grant is John Puskas, MD, professor of surgery and associate chief, division of cardiothoracic surgery at Emory University School of Medicine.

Explore further: New study unravels why common blood pressure medicine can fail

More information: T.A. Vassiliades et al. Clinical Outcomes After Hybrid Coronary Revascularization Versus Off-Pump Coronary Artery Bypass: A Prospective Evaluation Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery: 4, 299-306 (2009).

Related Stories

Robot-assisted minimally-invasive CABG surgery

Apr 07, 2008

Dr. Robert Poston is a pioneer in the use of robotics for minimally invasive cardiac surgery. He recently joined BMC as chief of cardiac surgery. With his arrival, BMC has become one of only one of 9 hospitals across the ...

Recommended for you

Technique could speed biologic drugs

1 hour ago

Antibodies are specific molecules that can lock onto a particular cellular structure to start, stop or otherwise temper a biological process. Because they are so specific, antibodies are at the forefront ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.